Figure GPS-22: Last year prevalence of cocaine use among all adults (aged 15 to 64), young adults (aged 15 to 34) and for the 15 to 24 year age group, in some EU countries
0.10.20.20.20.40.40.20.40.60.30.70.90.30.60.70.30.60.70.30.71.10.30.71.60.40.710.51.320.50.900.61.21.80.822.70.81.81.40.91.61.711.72.11.122.71.12.12.81.22.32.524.14.92.74.84.8<em>Notes:</em>Data are from the most recent national surveys available in each country (see epidemiological tables on population surveys, 2006 statistical bulletin).The age range is from between 15 and 18 to between 59 and 64. Variations in age ranges may slightly influence disparities between countries.Czech Republic: 2004; 18-64 y. <em>n</em>=3526; 18-34 y. <em>n</em>=1414; 18-24 y. <em>n</em>=586Denmark: 2000; 16-64 y. <em>n</em>=11825; 16-34 y. <em>n</em>=4141; 16-24 y. <em>n</em>=1754Germany: 2003; 18-59 y. <em>n</em>=8061; 18-34 y. <em>n</em>=3775; 18-24 y. <em>n</em>=1891Estonia: 2003; 15-64 y. <em>n</em>=; 15-34 y. <em>n</em>=646; 15-24 y. <em>n</em>=329Greece: 2004; 15-64 y. <em>n</em>=4351; 15-34 y. <em>n</em>=2620; 15-24 y. <em>n</em>=1785Spain: 2003; 15-64 y. <em>n</em>=12033; 15-34 y. <em>n</em>=2620; 15-24 y. <em>n</em>=2327France: 2002; 15-64 y. <em>n</em>=1744; 15-34 y. <em>n</em>=724; 15-24 y. <em>n</em>=345Ireland: 2002/03; 15-64 y. <em>n</em>=4918; 15-34 y. <em>n</em>=; 15-24 y. <em>n</em>=Italy: 2003; 15-54 y. <em>n</em>=11869; 15-34 y. <em>n</em>=5231; 15-24 y. <em>n</em>=2112Latvia: 2003; 15-64 y. <em>n</em>=4534; 15-34 y. <em>n</em>=; 15-24 y. <em>n</em>=Lithuania: 2004; 15-64 y. <em>n</em>=4207; 15-34 y. <em>n</em>=1814; 15-24 <em>n</em>=923Hungary: 2003; 18-54 y. <em>n</em>=; 18-34 y. <em>n</em>=2319; 18-24 y. <em>n</em>=943Netherlands: 2000/01; 15-64 y. <em>n</em>=14045; 15-34 y. <em>n</em>=6687; 15-24 y. <em>n</em>=Austria: 2004; 15-64 y. <em>n</em>=3980; 15-34 y. <em>n</em>=1754; 15-24 y. <em>n</em>=959Poland: 2002; 16-64 y. <em>n</em>=; 16-34 y. <em>n</em>=; 16-24 y. <em>n</em>=Portugal: 2001; 15-64 y. <em>n</em>=14186; 15-34 y. <em>n</em>=6406; 15-24 y. <em>n</em>=3099Slovakia: 2004; 15-64 y. <em>n</em>=1315; 15-34 y. <em>n</em>=578; 15-24 y. <em>n</em>=307Finland: 2004; 15-64 y. <em>n</em>=2352; 15-34 y. <em>n</em>=1031; 15-24 y. <em>n</em>=494UK (E&W): 2004/05; 16-59 y. <em>n</em>=28509; 16-34 y. <em>n</em>=9913; 16-24 y. <em>n</em>=6287Bulgaria: 2005; 18-60 y. <em>n</em>=1036; 18-34 y. <em>n</em>=433; 18-24 y. <em>n</em>=173Norway: 2004; 15-64 y. <em>n</em>=2669; 15-34 y. <em>n</em>=1238; 15-24 y. <em>n</em>=645See also 'General notes for interpreting data' on the <a href="../page055-en.html">Explanatory notes and help</a> page.<em>Sources</em>: <a href="http://www.emcdda.europa.eu/index.cfm?fuseaction=public.Content&nNodeID=435">Reitox national reports (2005)</a>, taken from population surveys reports or scientific articles. See also Tables <a href="gpstab11-en.html">GPS-10</a>, <a href="gpstab12-en.html">GPS-11</a> and <a href="gpstab19-en.html">GPS-18</a>.